DSpace Repository

Artemisinin production using genetic and metabolomic engineering

Show simple item record

dc.contributor.author RAKHMANOV, B.
dc.contributor.author IMAMKHODJAEVA, A.
dc.contributor.author UBAYDULLAEVA, Kh.
dc.contributor.author USMANOV, D.
dc.contributor.author MIRZAKHMEDOV, M.
dc.contributor.author SHERMATOV, Sh.
dc.contributor.author BURIEV, Z.
dc.date.accessioned 2024-02-09T09:44:12Z
dc.date.available 2024-02-09T09:44:12Z
dc.date.issued 2022
dc.identifier.citation RAKHMANOV, B., IMAMKHODJAEVA, A., UBAYDULLAEVA, Kh. et al. Artemisinin production using genetic and metabolomic engineering. In: International Scientific Conference on Microbial Biotechnology, 5th edition, Chișinău, Moldova, October 12-13, 2022. Chişinău, 2022, p. 98. ISBN 978-9975-3555-6-8; ISBN 978-9975-3555-7-5. en_US
dc.identifier.isbn 978-9975-3555-6-8
dc.identifier.isbn 978-9975-3555-7-5
dc.identifier.uri https://doi.org/10.52757/imb22.66
dc.identifier.uri http://repository.utm.md/handle/5014/26338
dc.description.abstract Currently, artemisinin extract from Artemisia remains the main source for medicine, and its concentration in this plant is 0.01–1.2% in dry weight, but its content is relatively higher in cultivated varieties. Artemisinin is the most effective agent used in the fight against malaria in the world, as well as its promising properties are reported to combat against several types of cancer, viral diseases like hepatitis, influenza, human immunodeficiency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 (coronavirus disease 2019). en_US
dc.language.iso en en_US
dc.publisher Institute of Microbiology and Biotechnology, Republic of Moldova en_US
dc.relation.ispartofseries International scientific conference "Microbial Biotechnology", 5th edition, 12-13 October 2022, Chisinau, Republic of Moldova;
dc.rights Attribution-NonCommercial-NoDerivs 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.subject medicinal plants en_US
dc.subject Artemisia annua en_US
dc.subject Plasmodium falciparum en_US
dc.subject human diseases en_US
dc.subject therapy en_US
dc.title Artemisinin production using genetic and metabolomic engineering en_US
dc.type Article en_US


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States

Search DSpace


Advanced Search

Browse

My Account